Abstract
Acylcarnitines (ACs) are fatty acid oxidation (FAO) intermediates and have been implicated in diet-induced insulin resistance, and elevated AC levels coincide with lower free carnitine and may reflect impaired FAO. Modulating carnitine availability by the administration of carnitine precursor γ-butyrobetaine (γBB) may facilitate FAO, thereby improving insulin sensitivity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
